Skip to main content
Veri Medtech Holdings Inc. (VRHI)
OTCMKTS · Delayed Price · Currency is USD
1.000
-0.010 (-0.98%)
Mar 6, 2026, 4:00 PM EST

Veri Medtech Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2011 FY 2010 FY 2009
Period Ending
 Sep '25 Dec '24 Dec '23 Dec '11 Dec '10 Dec '09
Revenue
11.8916.6522.160.060.060.06
Revenue Growth (YoY)
-46.35%-24.84%34117.17%8.88%-6.46%-
Cost of Revenue
3.044.266.070.010.020.05
Gross Profit
8.8512.3916.080.050.040.01
Selling, General & Admin
10.1912.6912.50.090.070.09
Other Operating Expenses
---0--
Operating Expenses
10.1912.6912.50.090.070.09
Operating Income
-1.34-0.33.58-0.04-0.03-0.08
Interest Expense
-0.1-0.11-0.1-0.01-0-
Other Non Operating Income (Expenses)
-0-00.05---
EBT Excluding Unusual Items
-1.44-0.413.53-0.05-0.04-0.08
Gain (Loss) on Sale of Assets
----0.3--
Pretax Income
-1.44-0.413.53-0.35-0.04-0.08
Net Income
-1.44-0.413.53-0.35-0.04-0.08
Net Income to Common
-1.44-0.413.53-0.35-0.04-0.08
Shares Outstanding (Basic)
181210211
Shares Outstanding (Diluted)
181210211
Shares Change (YoY)
72.60%11.24%440.21%35.18%27.82%-
EPS (Basic)
-0.08-0.040.34-0.18-0.03-0.07
EPS (Diluted)
-0.08-0.040.34-0.18-0.03-0.07
Free Cash Flow
0.170.053.35-0.340.010.18
Free Cash Flow Per Share
0.010.010.33-0.180.010.17
Gross Margin
74.42%74.39%72.59%81.12%63.06%15.93%
Operating Margin
-11.27%-1.81%16.18%-61.49%-53.89%-118.74%
Profit Margin
-12.11%-2.46%15.93%-536.33%-60.54%-118.74%
Free Cash Flow Margin
1.43%0.32%15.14%-525.76%10.93%290.11%
EBITDA
-1.33-0.33.58-0.04--
EBITDA Margin
-11.21%-1.78%16.18%-61.42%--
D&A For EBITDA
0.010.0100--
EBIT
-1.34-0.33.58-0.04-0.03-0.08
EBIT Margin
-11.27%-1.81%16.18%-61.49%-53.89%-118.74%
Advertising Expenses
---0.030.04-
Source: S&P Capital IQ. Standard template. Financial Sources.